UW20170
OPEN TO ACCRUAL
The Impact of DNA Repair Pathway Alt(s) Identified by ctDNA on Sensitivity to Rad223 in Bone mCRPC
UW22158
OPEN TO ACCRUAL
P2 Study of Cabozantinib and Nivolumab in mCRPC (CANOPY)
UW23084
OPEN TO ACCRUAL
Ph 1/2 Onc-392 + Lu 177 in m CRPC who progressed on NAH
UW23148
OPEN TO ACCRUAL
Ph2 single arm, SX-682 + Enza in Abi-resistant mCRPC
UW24003
OPEN TO ACCRUAL
Clinical Validation of a Circulating Tumor Cell AR Therapy Resistance Assay in Men w/ mCRPC